Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-Tb Specificity in BCG-Vaccinated Healthy Volunteers
NCT01242475Phase 2Completed
- Sponsor
- Statens Serum Institut
- Start
- Apr 2011
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of C-Tb in Tuberculosis (TB), sponsored by Statens Serum Institut. Primary endpoint: Diameter of induration. Started Apr 2011; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01242475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01242475.